STAT Plus: European Court adviser deals Glaxo a setback in ‘pay-to-delay’ case
In a setback to GlaxoSmithKline (GSK), a legal adviser to the European Court of Justice…
Category: legal
STAT Plus: Pharmalittle: Indian drug makers receive most FDA warning letters; most clinical trial results go unreported
Hello, everyone, and nice to see you again. We have finally returned from an extended…
Former Rep. Chris Collins sentenced to 26 months in prison in biotech insider trading scheme
Chris Collins, a former Republican lawmaker and longtime ally of President Trump, was sentenced Friday…
STAT Plus: Pharmalittle: FTC member favors Medicare negotiation on drug prices; BioMarin weighs pricing world’s most expensive drug
Good morning. Elizabeth Cooney here again, channeling Ed Silverman as another week draws to a…
.jpg)
STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?
Good morning. Elizabeth Cooney here in Boston while Ed Silverman hobnobs with industry types at…
STAT Plus: Supreme Court will review an Arkansas law governing pharmacy benefit managers
In a move with the potential to affect health care costs, the U.S. Supreme Court…
STAT Plus: Bristol-Myers and Sanofi accuse Hawaii of violating their free speech rights
In an unusual move, two of the world’s biggest drug makers — Bristol-Myers Squibb (BMY)…
Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
PIKEVILLE, Ky. — A year and a half after the opioid painkiller OxyContin went on…
Opinion: 3 legal challenges could derail out-of-network surprise medical bills
Surprise medical bills have become the bane of many Americans who are seen in emergency…
STAT Plus: Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
A federal judge dealt the pharmaceutical industry a setback by declining to block a new…
A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?
WASHINGTON — Since the Food and Drug Administration can’t figure out whether supplements that contain…
STAT Plus: Feds says a CVS long-term-care pharmacy improperly refilled prescriptions, jeopardizing patients
Omnicare, the nation’s largest long-term-care pharmacy, was accused by federal authorities of fraudulently billing government…
STAT Plus: Bankrupt uBiome preliminarily sells patents for 1% of the poop-testing startup’s original valuation
Bankrupt microbiome-testing startup uBiome, once valued at $600 million by Silicon Valley investors, preliminarily sold…
STAT Plus: U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
The U.S. Patent and Trademark Office has removed a senior legal adviser from a high-profile…
STAT Plus: Bribing doctors in India is allegedly a widespread practice
Seeking to juice profits, some Indian drug makers bribe doctors with credit cards, free trips,…
STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics
A small drug maker called Rising Pharmaceuticals agreed to pay more than $3 million to…
The history of OxyContin, told through unsealed Purdue documents
PIKEVILLE, Ky. — STAT’s multiyear legal battle to unseal secret Purdue Pharma files in a…
Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show
PIKEVILLE, Ky. — In the early days of OxyContin, Dr. Richard Sackler, a member of…
How difficult is a $1 billion health-tech fraud? A new indictment makes it sound easy
Building a health-technology startup on nothing but hot air may be easier than you’d think…
STAT Plus: Merck is probed by Spain’s antitrust regulator for allegedly delaying competition for a contraceptive
The antitrust regulator in Spain has accused Merck (MRK) of working with other companies to…
STAT Plus: Generic trade group sues California for an ‘unconstitutional’ law banning pay-to-delay deals
A newly enacted California law that bans so-called pay-to-delay deals between drug makers would reduce…
STAT Plus: Patient charity settles allegations it helped MS drug makers pay kickbacks
A patient assistance charity has agreed to pay $4 million to settle allegations that it…